Shuoshi Biotech announced that 1.751 million unrestricted tradable shares held by the controlling shareholder Runkang Biotech were judicially frozen, accounting for 5.11% of the total number of shares held by it and 1.41% of the company's total share capital. The freeze period is from October 9, 2026 to October 8, 2029. This freeze will not cause changes in the company's controlling shareholders or actual controllers, nor will it have a significant impact on the company's daily production and operation.

Shuoshi Biotech announced that 1.751 million unrestricted tradable shares held by the controlling shareholder Runkang Biotech were judicially frozen, accounting for 5.11% of the total number of shares held by it and 1.41% of the company's total share capital. The freeze period is from October 9, 2026 to October 8, 2029. This freeze will not cause changes in the company's controlling shareholders or actual controllers, nor will it have a significant impact on the company's daily production and operation.